New Drug Development Process/Drug Discovery and Attorney Experts

Tom J Parry, PhD, MBA--Drug Discovery and development, Pharmacology, PK/TK,

toxicology, business strategy, SBIR/STTR grants

Andrew Eisen, MD, PhD--Translational medicine, biomarker strategies and PK/PD-clinical pharmacology, clinical trials

Ronald Zolty, MD, PhD--Cardiology and translational medicine, clinical trials

Mark DellaPorta, Esq--highly experienced biopharmaceutical R&D attorney

Harshini Neelakantan, PhD—experienced biotech entrepreneur, SBIR/STTR grants

Our People